These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 26833119)
1. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections. Donovan C; Bourke JE; Vlahos R Trends Pharmacol Sci; 2016 Apr; 37(4):252-261. PubMed ID: 26833119 [TBL] [Abstract][Full Text] [Related]
2. Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies. Watson A; Spalluto CM; McCrae C; Cellura D; Burke H; Cunoosamy D; Freeman A; Hicks A; Hühn M; Ostridge K; Staples KJ; Vaarala O; Wilkinson T Am J Respir Crit Care Med; 2020 Jan; 201(1):83-94. PubMed ID: 31461630 [No Abstract] [Full Text] [Related]
3. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Hewitt R; Farne H; Ritchie A; Luke E; Johnston SL; Mallia P Ther Adv Respir Dis; 2016 Apr; 10(2):158-74. PubMed ID: 26611907 [TBL] [Abstract][Full Text] [Related]
4. Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. Contoli M; Marku B; Conti V; Saturni S; Caramori G; Papi A Minerva Med; 2009 Dec; 100(6):467-78. PubMed ID: 20010482 [TBL] [Abstract][Full Text] [Related]
5. Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity. Werder RB; Zhang V; Lynch JP; Snape N; Upham JW; Spann K; Phipps S J Allergy Clin Immunol; 2018 May; 141(5):1607-1619.e9. PubMed ID: 28947081 [TBL] [Abstract][Full Text] [Related]
6. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Mallia P; Contoli M; Caramori G; Pandit A; Johnston SL; Papi A Curr Pharm Des; 2007; 13(1):73-97. PubMed ID: 17266589 [TBL] [Abstract][Full Text] [Related]
7. Viral-associated exacerbations of asthma and COPD. Traves SL; Proud D Curr Opin Pharmacol; 2007 Jun; 7(3):252-8. PubMed ID: 17369093 [TBL] [Abstract][Full Text] [Related]
8. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. Ramirez-Carrozzi V; Sambandam A; Zhou M; Yan D; Kang J; Wu X; Suto E; Baca M; Austin C; Xu M; Lee W; Pappu R J Allergy Clin Immunol; 2017 Feb; 139(2):705-708.e6. PubMed ID: 27697499 [No Abstract] [Full Text] [Related]
9. Interleukin-13: prospects for new treatments. Brightling CE; Saha S; Hollins F Clin Exp Allergy; 2010 Jan; 40(1):42-9. PubMed ID: 19878194 [TBL] [Abstract][Full Text] [Related]